The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Projection of Diabetes Burden Through 2050
Open accessAbstract
OBJECTIVE: To project the number of people with diagnosed diabetes in the U.S. through 2050, accounting for changing demography and diabetes prevalence rates. RESEARCH DESIGN AND METHODS: We combined age-, sex-, and race-specific diagnosed diabetes prevalence rates-predicted from 1980-1998 trends in prevalence data from the National Health Interview Survey-with Bureau of Census population demographic projections. Sensitivity analyses were performed by varying both prevalence rate and population projections. RESULTS: The number of Americans with diagnosed diabetes is projected to increase 165%, from 11 million in 2000 (prevalence of 4.0%) to 29 million in 2050 (prevalence of 7.2%). The largest percent increase in diagnosed diabetes will be among those aged > or =75 years (+271% in women and +437% in men). The fastest growing ethnic group with diagnosed diabetes is expected to be black males (+363% from 2000-2050), with black females (+217%), white males (+148%), and white females (+107%) following. Of the projected 18 million increase in the number of cases of diabetes in 2050, 37% are due to changes in demographic composition, 27% are due to population growth, and 36% are due to increasing prevalence rates. CONCLUSIONS: If recent trends in diabetes prevalence rates continue linearly over the next 50 years, future changes in the size and demographic characteristics of the U.S. population will lead to dramatic increases in the number of Americans with diagnosed diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The rates of type 2 diabetes and insulin resistance are significantly greater in the elderly population compared to young adults,91, 92 leading to greater risk for cardiovascular events.”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Increasing Prevalence of Overweight Among US Adults
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,544
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384
Type 2 diabetes among North adolescents: An epidemiologic health perspective
Fagot‐Campagna, A., Pettitt, D. J., Engelgau, M. M., Burrows, N. R., Geiss, L. S., Valdez, R. A., Beckles, G. L., SAADDINE, J. B., Gregg, E. W., Williamson, D. F., et al. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105141 · Cited by 1,123
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042
Screening for type 2 diabetes.
Engelgau, M. M., Narayan, K. M. V., & Herman, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1563 · Cited by 1,026
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Diabetes — a common, growing, serious, costly, and potentially preventable public health problem
Narayan, K. M. V., Gregg, E. W., Fagot‐Campagna, A., Engelgau, M. M., & Vinicor, F. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00183-2 · Cited by 312
Cited by
Sorted by citations
Items 701–800 of 1,000
Depression in Diabetic Patients
Farshid, S., Cheraghi, F., & Allahverdipour, H. (2006) · Journal of Research in Health Sciences · doi:10.34172/jrhs6298 · Cited by 4
Acercamiento a una problemática trascendente: el síndrome metabólico
Rodríguez, J. L. V. (2005) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
De, D., Chatterjee, K., Jana, K., Ali, K. M., Bera, T. K., Samanta, R., & Ghosh, D. (2013) · Biomarkers and Genomic Medicine · doi:10.1016/j.bgm.2013.09.001 · Cited by 4
Diabetes Management System Based on Ubiquitous Healthcare
Kim, J., & Ahn, C. W. (2011) · Journal of Korean Diabetes · doi:10.4093/jkd.2011.12.3.133 · Cited by 4
Neumiller, J. J., Sclar, D. A., Robison, L. M., Setter, S. M., & Skaer, T. L. (2009) · Primary care diabetes · doi:10.1016/j.pcd.2009.07.001 · Cited by 4
The Impact of Content-Based Network Technologies on Perceptions of Nutrition Literacy
Brewer, H. J., Church, E. M., & Brewer, S. L. (2016) · American Journal of Health Education · doi:10.1080/19325037.2016.1178609 · Cited by 4
“nutrition has been identified as a major determinant in the prevention of type 2 diabetes, obesity, and cardiovascular disease.(60,61) Results of this study indicate that reported use of content-based networks, specifically Pinterest, provides consumers with access to new and”
BackgroundMukhopadhyay, S., Samaddar, S., Solis, A. O., & Roy, A. (2018) · Decision Sciences · doi:10.1111/deci.12348 · Cited by 5
ESTADO DE SAÚDE E REPRESENTAÇÕES SOBRE A DOENÇA NA PERSPECTIVA DE PORTADORES DE DIABETES MELLITUS
Santos, L. S. C., Andrade, A. T. D., Silva‐Rodrigues, F. M., & de Ávila, L. K. (2021) · Revista Baiana de Enfermagem · doi:10.18471/rbe.v35.42071 · Cited by 4
“como problema de saúde pública e uma doença responsável por uma das maiores causas de mortalidade do mundo((17)).”
BackgroundEvidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease
Iida, O., Takahara, M., & Mano, T. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17058 · Cited by 4
Flavonoides y Fenoles totales con actividad hipoglicemiante en semillas de Syzygium jambos
González-Blas, M. V., García-Armas, J. M., & ́érrez, L. A. H.-G. (2022) · Revista Salud Amazónica y Bienestar · doi:10.51252/rsayb.v1i1.272 · Cited by 4
Fransson, T., Gottsäter, A., Abdulrasak, M., Malina, M., & Resch, T. A. (2023) · Vascular and Endovascular Surgery · doi:10.1177/15385744231171746 · Cited by 4
Choi, E., Kim, M.-S., Cho, J., Kim, S., Kwon, E. K., Kim, Y., Kang, D., & Cho, S. Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-38982-1 · Cited by 5
Glycemic control and prescription profiles in internal medicine inpatients: The role of frailty
Arévalo‐Lorido, J. C., Carretero‐Gómez, J., Rodriguez, P. V., Gómez‐Huelgas, R., Silvente, C. M., Lora, F. J. S., Ares, E. I., Pelegrín, A. P. I., Hernández, O. P., & Ena, J. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.022 · Cited by 4
McFarlane, S. I., Farag, A. F., Gardner, D., & Sowers, J. R. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:307 · Cited by 4
Dash, D. K., Ghosh, T., Yeligar, V. C., Kandasamy, M., Nayak, S. S., Maiti, B. C., & Maity, T. K. (2007) · Oriental Pharmacy and Experimental Medicine · doi:10.3742/opem.2007.7.3.244 · Cited by 4
O’Hanlon, C. E., Cooper, J. M., Lee, S. M., John, P. M., Churpek, M. M., Chin, M. H., & Huang, E. S. (2017) · MDM Policy & Practice · doi:10.1177/2381468317713718 · Cited by 4
“8 million by 2050.(2) Diabetes treatment goals have historically aimed to achieve near-normal levels of glucose (hemoglobin A1c [HbA1C] \7%), blood pressure (\130/80 mmHg), and cholesterol to reduce the risk of complications.”
BackgroundDiagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-2 · Cited by 4
Smith, L. L., Brent, R. L., Cohen, S. M., Doerrer, N. G., Goodman, J. I., Greim, H. A., Holsapple, M. P., & Lightfoot, R. M. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802486378 · Cited by 4
“Major changes in the prevalence of diseases in the aging population are occurring over time (Boyle et al., 2001; Centers for Disease Control and Prevention, 2003, 2007b; Cowie et al., 2006; Crimmins and Saito, 2000; Flegal et al., 2002; Majeed and Aylin, 2005; Wilmoth and Longino, 2006).”
BackgroundDube, S., Sharma, V., Dubey, T., Mehta, A., & Gour, D. (2007) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.37032 · Cited by 4
Inpatient management of diabetes and hyperglycemia
John, R., & Fogelfeld, L. A. (2004) · Disease-a-Month · doi:10.1016/j.disamonth.2004.07.003 · Cited by 4
Simulated Estimates of Pre-Pregnancy and Gestational Diabetes Mellitus in the US: 1980 to 2008
Mayorga, M. E., Reifsnider, O. S., Neyens, D. M., Gebregziabher, M., & Hunt, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073437 · Cited by 4
“Projections of diabetes prevalence in the US population have been completed through 2030 [19] and 2050 [20] and also globally through 2030 [21].”
BackgroundEvaluation of type 2 diabetes mellitus medication management and control in older adults.
Thompson, A., Griend, J. V. V., Linnebur, S., & Saseen, J. (2013) · The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists · doi:10.4140/tcp.n.2013.296 · Cited by 4
The Challenges of Addressing Primary Prevention of Diabetes
Namageyo-Funa, A., & Nanavati, P. (2008) · Journal of Public Health Management and Practice · doi:10.1097/01.phh.0000303409.66485.47 · Cited by 4
Estimating Prevalences of Sensitive Problems From Nonsensitive Data
Heyman, R. E., & Slep, A. M. S. (2010) · Journal of Interpersonal Violence · doi:10.1177/0886260510362881 · Cited by 4
“, 2004) and predictors (e.g., demographic variables; Boyle et al., 2001) that are measured objectively with very little error.”
BackgroundANTI-DIABETIC ACTIVITY OF SPHAERANTHUS INDICUS LINN. EXTRACTS IN ALLOXAN- INDUCED DIABETIC RATS
Kharkar, R., Pawar, D. P., & Shamkuwar, P. B. (2013) · Cited by 4
Diabetes Mellitus and Risk of Colorectal Cancer
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · Cited by 4
Khan, M. R. I. (2012) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-25601218 · Cited by 4
Discontinued drugs in 2005: endocrine and metabolic
Colca, J. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.129 · Cited by 4
“Background Type 2 diabetes remains one of the largest undertreated areas of medical need that contributes to sky-rocketing healthcare costs [1].”
BackgroundSituating Stress: Lessons from Lay Discourses on Diabetes
Schoenberg, N. E., Drew, E. M., Stoller, E. P., & Kart, C. S. (2009) · doi:10.1093/acprof:oso/9780195374643.003.0004 · Cited by 4
Bartnik, M. (2005) · Figshare · Cited by 4
Predictive validity of different definitions of hypertension for type 2 diabetes
Gulliford, M. C., Charlton, J., & Latinovic, R. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.629 · Cited by 4
“hypertension but these are the same groups that have the highest risk of developing pre-diabetes or diabetes [16,25].”
BackgroundMethodRecognising and Treating the Diabetic Patient in Cardiovascular Care
Bartnik, M., Malmberg, K., & Rydén, L. (2002) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(02)00034-8 · Cited by 4
Should all diabetic patients receive statins?
Garcia, P. J., & Spellman, C. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0059-z · Cited by 4
Inclusion of a glycogen regulation mathematical model into a contextual metabolic framework
Todd, A. J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/g6q4-ky27 · Cited by 4
RSSDI guidelines for management of type 2 diabetes mellitus in older adults
Jagadeesha, A., Viswanathan, V., Agarwal, S., Maheshwari, A., Virmani, A. K., Nagendra, L., Amarnath, A., Chawla, M. S., Jethwani, P., Parikh, R. M., et al. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01613-8 · Cited by 4
The Current and Forecasted Status of Type 2 Diabetes in the Arab Society of Israel
Zalan, A. A., Sheikh-Muhammad, A. A., Khatib, M., & Sharkia, R. A. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210405100108 · Cited by 3
Wright, C. B., & Caunca, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_13 · Cited by 3
Gaddeti, V., Bodda, Y., Kamani, C., Pratap, T., & Sateesh, J. (2024) · Students Conference on Engineering and Systems · doi:10.1109/sces61914.2024.10652320 · Cited by 3
“In India, the prevalence of diabetes is particularly high, with an estimated 74 million adults living with the condition in 2021, projected to rise to 124 million by 2045 [7].”
BackgroundLevine, J. A., Kaihara, K. A., Layden, B. T., & Wicksteed, B. L. (2016) · Islets · doi:10.1080/19382014.2016.1198457 · Cited by 3
Diabetes mellitus and cognitive impairment
Luchsinger, J. A., & Florez, H. J. (2007) · CRC Press eBooks · doi:10.3109/9780203931592-5 · Cited by 4
Pattern Recognition of Diabetes Related Biomarkers
Staden, R. S., Mitrofan, G., & Ionescu-Tirgoviste, C. (2018) · Electroanalysis · doi:10.1002/elan.201800523 · Cited by 3
Antioxidant Supplements in Obesity and Metabolic Syndrome
Casuso, R. A., & Huertas, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00013-1 · Cited by 3
Diabetic retinopathy detection in ocular imaging by dictionary learning
Amini, Z., Kafieh, R., Mousavi, E., & Rabbani, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817440-1.00013-9 · Cited by 3
Sunija, A. P., Krishna, A. K., Gopi, V. P., & Palanisamy, P. (2022) · Biomedical Engineering Applications Basis and Communications · doi:10.4015/s1016237222500259 · Cited by 3
Solley, K. D., Berges, A. J., Phillips, E. J., Ding, A. S., Diaz, C. M., Pramanik, S., Yazdi, Y., & Parikh, K. S. (2022) · Cornea · doi:10.1097/ico.0000000000003096 · Cited by 3
Bayesian Model Projecting Cardiovascular Disease Related Mortality Trends in the United States
Deo, S. V., Al-Kindi, S. G., Salerno, P. R. V. D. O., Cotton, A., Elgudin, Y. E., Virani, S. S., Nasir, K., Petrie, M. C., Sattar, N. A., & Rajagopalan, S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035922 · Cited by 3
Zatońska, K., Połtyn–Zaradna, K., Einhorn, J., Wołyniec, M., Gaweł-Dąbrowska, D., Szuba, A., & Zatoński, W. A. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0523-4 · Cited by 3
CalorieKiller: Burning Calories using Mobile Exergame with Wearables
Reiaz, S., Mcharek, I., Shabbir, R., Lim, H. C., Talukder, D., Udasi, R., Malek, M. F. A., & Malek, K. A. (2019) · SeGAH ... IEEE ... International Conference on Serious Games and Applications for Health/IEEE International Conference on Serious Games and Applications for Health · doi:10.1109/segah.2019.8882453 · Cited by 3
“Another study claims that from 2000 to 2050 the individuals diagnosed with diabetes will increase by 165% [3].”
BackgroundNadi, Z., Bayat, M., Karami, H., Parastesh, M., & Bayat, P. (2021) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2021.9287 · Cited by 4
“Type 2 diabetes or also known as non-insulin dependent diabetes (NIDDM) with 90% of cases being the most frequent type of diabetes (2).”
BackgroundWaist circumference and impaired fasting glucose screening in a Mediterranean population
Baena-Díez, J. M., Elosúa, R., Cano-Pérez, J. F., Masiá, R., Sala, J., Marrugat, J., & Schröder, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.08.007 · Cited by 3
“Type 2 diabetes, a costly disease that predisposes to various types of cardiovascular events, has reached epidemic proportions worldwide [1].”
BackgroundRyan, J., Velez, F. F., Chung‐Bridges, K., Lewis, J. E., Schwartz, R. S., & Jennings, T. E. (2007) · Insulin · doi:10.1016/s1557-0843(07)80039-x · Cited by 3
Educating Patients With Diabetes About Cardiovascular Disease Risk
Quinn, L. (2004) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2004.02002.x · Cited by 3
Neumiller, J. J., Sclar, D. A., Robison, L. M., Setter, S. M., & Skaer, T. L. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.12.001 · Cited by 3
“Our objectives were to discern the following: (1) the characteristics of ambulatory patients aged ≥20 years having an office-based physician–patient encounter (visit) for DM (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 250.”
BackgroundShahady, E. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.1.29 · Cited by 3
Trends in BMI and obesity in U.S. women of childbearing age during the period of 1980–2010
Mayorga, M. E., Reifsnider, O. S., Yi, Z., & Hunt, K. J. (2014) · Health Systems · doi:10.1057/hs.2014.29 · Cited by 3
Law, M. G., Komura, S., Murchison, A. P., & Pizzi, L. T. (2013) · PubMed Central · Cited by 3
Influence of the Two-Layer Preservation Method on Human Pancreatic Islet Isolation: A Meta-Analysis
Li, X., Zhang, J., Sang, L.-X., Chu, Z., & Dong, M. (2015) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000391 · Cited by 3
“Diabetes affects more than 200 million people worldwide (1).”
BackgroundEmerging Roles of Micrornas in Diabetic Cardiomyopathy
Fomison‐Nurse, I. C. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000394 · Cited by 2
“It is therefore imperative for new and innovative ways to diagnose and treat such complications early on in the disease progression [2].”
BackgroundLauner, L. J., & Wright, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-70715-0_14 · Cited by 3
Genetic Algorithms and Classification Trees in Feature Discovery: Diabetes and the NHANES database
Heredia‐Langner, A., Jarman, K. H., Amidan, B. G., & Pounds, J. G. (2013) · Cited by 3
Chapter 9 Starch: Analytical and Structural Aspects
Bertoft, E., & Nilsson, L. (2016) · CRC Press eBooks · doi:10.1201/9781315372822-10 · Cited by 4
Wong, T., Brovman, E. Y., Rao, N., Tsai, M. H., & Urman, R. D. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4029 · Cited by 3
“7 million [1], and forecasting models have shown that the prevalence of diabetes will continue to increase over the next few decades [2-4] as 84 million Americans are estimated to be living with prediabetes in 2018.”
BackgroundDouble posterior lateral plating arthrodesis for charcot ankle: A case series
Pradana, A. S., Phatama, K. Y., Mustamsir, E., Cahyono, G. D., Oktafandi, I. G. N. A. A., & Hidayat, M. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102250 · Cited by 3
Evolution of C-Reactive Protein as a Cardiac Risk Factor
D’Amore, P. J. (2005) · Laboratory Medicine · doi:10.1309/d96t-l8y8-c5qe-rj8p · Cited by 3
Yan, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kpne-0v56 · Cited by 3
Translation Research in Diabetes
Glasgow, R. E., Bayliss, E. A., & Estabrooks, P. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-008-9_16 · Cited by 3
“Further, the prevalence of diabetes is projected to increase by almost 40% by 2010 ( 5 ).”
Background(2005) · PsycEXTRA Dataset · doi:10.1037/e403672008-001 · Cited by 3
Toward prevention and control of type 2 diabetes: challenges at the U.S.-Mexico border and beyond.
Bowman, B. A., & Vinicor, F. (2005) · PubMed Central · Cited by 3
Fransson, T., Mohammed, Y., Gottsäter, A., & Resch, T. A. (2025) · Journal of Endovascular Therapy · doi:10.1177/15266028251388746 · Cited by 2
Ali, P. R., Rakshitha, G., Rajesham, V. V., Shivani, K. N. L., Sagapola, R., & Sravanthi, S. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100502 · Cited by 2
Aguilar, S., Estrada, R. C., García, M. M., & Barrientos, J. V. R. (2011) · Revista de especialidades m�dico-quir�rgicas · Cited by 2
Boamah, E., & Druye, A. A. (2022) · Digital Library Perspectives · doi:10.1108/dlp-11-2021-0098 · Cited by 2
Gaye, N. D., Ngaïdé, A. A., Mingou, J. S., Wague, M., Dioum, M., Mbaye, A., & Kane, A. D. (2024) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2024.1410055 · Cited by 2
“Furthermore, it is indicated that by 2030, the majority of cases will come from India, China, and the United States [4].”
Johansson, M., Åkesson, A., Nilsson, P. M., & Melander, O. (2024) · BMC Public Health · doi:10.1186/s12889-024-20435-7 · Cited by 3
“%) in 2018 [1], and rates are expected to increase further primarily due to an aging population, changing racial/ethnic diversity, as well as changes in obesity rates and lifestyle factors [2].”
BackgroundAlhasaniah, A. H., Sadiq, A., Awadh, A. A. A., Asiri, Y. I., Rezigue, M. M., Zafar, R., Ahmad, S., Jan, M. S., & Mahnashi, M. H. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2509158 · Cited by 2
Mohammed, E., Salmi, I. A., Riyami, D. A., Khan, S. A., Riyami, M. A., Rahbi, F. A., & Hannawi, S. (2022) · Open Journal of Nephrology · doi:10.4236/ojneph.2022.121017 · Cited by 2
“In 2013, more than 30 billion dollars from Medicare expenditure were spent on management of end-stage kidney disease (ESKD), 14 billion of which were due to DKD [6] [7] [8].”
BackgroundMethodInfluentialDiagnostic Criteria and Classification of Diabetes
Gospin, R., & Zonszein, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-1 · Cited by 2
Fluorescence Biosensors for Continuously Monitoring the Blood Glucose Level of Diabetic Patients
D’Auria, S., Ghirlanda, G., Parracino, A., de Champdoré, M., Scognamiglio, V., Staiano, M., & Rossi, M. (2006) · Springer eBooks · doi:10.1007/0-387-33015-1_5 · Cited by 2
Llorente, M. D., & Malphurs, J. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_14 · Cited by 2
Intervención educativa sobre Diabetes Mellitus en pacientes portadores de la enfermedad
Cobiella, D. M. R., Moles, A. G. M., Taboada, J., & Correa, L. R. (2011) · Revista Archivo Médico de Camagüey · Cited by 2
Diabetes mellitus: The Pandemic of 21st Century!
Gupta, R. K., Johri, S., & Saxena, A. M. (2009) · Cited by 2
Management of Type 2 Diabetes Mellitus with Basal-Prandial Insulin Therapy: A Case-Based Review
Davis, S. N. (2007) · Insulin · doi:10.1016/s1557-0843(07)80040-6 · Cited by 2
Lee, Y. J., Jeong, M. H., Kim, J. H., Park, J., Kim, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Baik, S. H., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.3.232 · Cited by 2
Ludwig, S. M., Griffith, E. J., McQuillen, K. I., Anderson, W. A., & Kvern, B. L. (2006) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(06)03008-5 · Cited by 2
Petroianu, G. A., & Schmitt, A. (2002) · Cited by 2
Michimi, A., Ellis‐Griffith, G., Lartey, G. K., Ellis-Griffith, C., & Hunt, M. L. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.09.001 · Cited by 2
In a Language Spoken and Unspoken: Nurturing Our Practice as Humanistic Clinicians
Bell, K. W. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.11.002 · Cited by 2
Multiple Source Biosimilar Insulin, What’s a Provider to Do?
Carter, A. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813511748 · Cited by 2
“In the United States alone we expect to see a 165% increase in persons with diabetes by 2050.(2) Diabetes and subsequent comorbid chronic disease that occurs from poor glycemic control is expanding global health care costs exponentially.”
BackgroundMontezuma, R., & Freire, W. B. (2005) · Cited by 2
Babu, K., Nayak, N., & Hebbal, G. V. (2015) · International journal of medical and health sciences · Cited by 2
Chhabra, S., & Chopra, S. (2016) · Journal of Pregnancy and Child Health · doi:10.4172/2376-127x.1000235 · Cited by 2
Yuki, M. (2018) · Annals of Musculoskeletal Medicine · doi:10.17352/amm.000011 · Cited by 2
“The number of DM patients who need to undergo THA or TKA have been increasing [9].”
BackgroundReference guide of physical activity programs for older adults; a resource for planning intervention
Moran, S., Brown, D. R., Caspersen, C. J., & Thomas, G. D. (2007) · Cited by 2
Krech, E. D., LaPierre, L. J., Tuncdemir, S., Gurdal, A. E., Haas, E. G., Arnold, P. M., & Friis, E. A. (2021) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2021.104976 · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_7 · Cited by 2
Impact of Curcumin on Aging: Its Manifestations and Limitations
Banji, D., & Banji, O. J. F. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_13 · Cited by 2
Neumiller, J. J., Sclar, D. A., Robison, L. M., Maldonado, A. L., Setter, S. M., & Skaer, T. L. (2010) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709358463 · Cited by 3
Andrés Jadue, T., Roberto González, L., & Ll, M. J. I. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012000500014 · Cited by 2
Overview of the Obesity Epidemic and Its Relationship to Cardiovascular Disease
Bassuk, S. S., & Manson, J. A. E. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.001 · Cited by 2
The Evolution of a National Public Health Initiative on Diabetes and Women's Health: A Model Process
Alfaro-Correa, A., Beckles, G. L., Benjamin, C., Bowman, B. A., Green, Y., Green-Phillips, A., Hardy, R. I., Harper, S., Haynie-Mooney, N., Loner, N., et al. (2003) · Journal of Women s Health · doi:10.1089/154099903770948050 · Cited by 2
Metadata
- Authors
- Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- RTI International (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-11-01
- Volume
- 24
- Issue
- 11
- Pages
- 1936-1940
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2060151575
- Cited by
- 1,004
- References
- 14
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 23 · 2023: 16 · 2022: 27 · 2021: 27 · 2020: 23 · 2019: 28 · 2018: 25 · 2017: 30 · 2016: 50 · 2015: 30 · 2014: 46 · 2013: 50 · 2012: 59
- FWCI
- 29.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- diabetes prevalence, population projections, age-specific prevalence, racial and ethnic disparities, older adults, Black men, population growth, diabetes epidemiology, United States
- MeSH terms
- Adolescent, Adult, Aged, Black or African American, Child, Demography, Diabetes Mellitus, Ethnicity, Female, Forecasting, Humans, Male, Middle Aged, Sex Factors, United States, Prevalence, Cost of Illness, Age Distribution, White People, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review